ERBB, MDRM, and RFMK Remain On Top Of Our Watch


Hi Everyone & Welcome New Subscribers,

Wow! What else can we say? After an amazing start to the week, as we somewhat anticipated, we’re keeping all three of our “Monday monsters” on for watch Tuesday; we believe they’ve more than warranted such focus. 

ERBB  Potential Continued Breakout – (Tranzbyte Corp.) – closed up 32.89%, at .0994 a share, on more than 296 million shares traded Monday. The Tranzbyte Corporation now becomes a driving force behind Altitude Organix, OneBodē Nutraceuticals, The YO! Debit Card, and ProximaRF. Visit their website, HERE, for more information. ERBB started the week in similar fashion to how it ended the week last week, closing just below another new high today of .0995, and well on it’s way to eclipsing the psychological level of .10 early tomorrow. Judging by where the stock closed, it’d be pretty surprising if it doesn’t open over .10 tomorrow; where will it go after though? Can ERBB move as high as .11 or .12 tomorrow? We’ll just have to see if the momentum and volume are strong enough, but it’s certainly possible. Keep ERBB on top of your watch.

MDRM  Potential Continued Breakout – (Modern Mobility Aids, Inc.) – closed up 36.36%, at .15 a share, on more than 5.7 million shares traded Monday. In February 2014, the business focus of MDRM evolved with a rapid expansion strategy in the life sciences and healthcare industry, with a focus on production of Medical Marijuana. A mandate was created to acquire companies within the bio-pharma and alternative medicine sectors targeting both innovative research and development as well as scalable licensed, manufacturing capacity in three niche market segments. Shares of MDRM
 opened the week a full .02 above Friday’s close of .11, holding a low of .12, and retested it’s 52 week high of .16, but failed to break through. 
MDRM traded a record amount of volume today (as far as this year is concerned), following a positive Seeking Article which gave credibility to the company’s business, and might keep moving higher as a result. MDRM closed over .13, and now it will need to break .16 in order to continue higher; if it fails to get through .16 tomorrow, it could go back to .11 or below before moving back up. Keep it on close watch.

RFMK  Potential Continued Breakout – (Rapid Fire Marketing, Inc.) – closed up 71.88%, at .011 a share, on more than 684.9 million shares traded Monday. The core business in Rapid Fire Marketing is the Vapor Inhaler. Rapid Fire Marketing, Inc. is a developer, producer and of vapor inhaler products. The Vapor Inhaler (V.I.) is an innovative and disruptive technology for medical cannabis patients and nicotine and herb users around the world. RFMK had an amazing day today, nearly doubling the gains of both ERBB and MDRM on Monday, after making a strong break past .008 (which we talked about on our blog Sunday), and reached a new high of .012. If RFMK opens at a new high tomorrow, which we anticipate it might, it could reach .015-.02 before seeing any consolidation. Keep it on close watch.

Sign Up-> HERE <-To Be Among The First To Receive Our Next Winning Pick!

Happy Trading!

The Penny Stock Experts Team at

Follow us on Twitter @Todayspickis

Please read our legal Disclaimer below:

This disclaimer is to be read in its entirety, and fully understood before using or joining the email list. reserves the right to revise, amend, or modify our Privacy Policy, our Disclaimer, and our other policies and agreements at any time and in any manner by updating their postings. You are responsible for regularly reviewing these terms, conditions, and notices, and any additional terms posted on Your continued use of the website and/or email newsletter after the effective date of such changes constitutes your acceptance of and agreement to such changes. If we should update this disclaimer, we will post the updates to this page on

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE OR IN ONE OF OUR NEWSLETTERS.Neither nor any of its employees, affiliates, subsidiaries, or family members are registered investment advisers or registered stock brokers either within the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority and shall not be liable for any direct, indirect, incidental, special or consequential damages arising out of, or resulting from the use or inability to use this site, including but not limited to damages for the loss of capital, funds, profits, use, data, or any and all other possible damages, even if such party has been advised of the possibility of such damages resulting from the use of this site and all information contained on this site. We are neither licensed nor qualified to provide investment advice.

The information contained on our website or in any of our newsletters should be viewed as commercial advertisement and is not intended to be investment advice. Any information found on our website, or in any of our newsletters is not provided to any particular individual with a view toward their individual circumstances. The information contained on our website, and in any newsletter we distribute, is not an offer to buy or sell securities. We distribute opinions, comments, and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any of the company’s profiled based solely on information contained in our newsletter or website. Individuals should assume that all information contained on our website or in one of our newsletters about profiled companies is not trustworthy unless verified by their own independent research. may buy or sell shares on the open market that may positively or negatively affect the stock price before or after this mailing and subscribers are to be fully aware that and it’s affiliates can buy or sell more shares at any time. and/or it’s affiliates may receive compensation for e-mail alerts. To view our full compensation disclosure please visit does not accept free-trading shares as a form of payment.